Stocks in Focus on November 24: IRCTC, Coal India, Ingersoll-Rand India, AstraZeneca Pharma to Real Estate Sector; here are the 5 Newsmakers of the Day

Domestic benchmark indices ended with modest gains on Monday, November 23, 2020. The BSE 30-share index, Sensex, rose 195 points or 0.44 per cent to settle at 44,077. The NSE Nifty-50 index also added 67 points or 0.52 per cent to settle at 12,926. But certain stocks came in news after the market was closed

Stocks that are likely to remain in focus today include, IRCTC, Coal India, Ingersoll-Rand India and AstraZeneca Pharma. Source: Reuters

Domestic benchmark indices ended with modest gains on Monday, November 23, 2020. The BSE 30-share index, Sensex, rose 195 points or 0.44 per cent to settle at 44,077. The NSE Nifty-50 index also added 67 points or 0.52 per cent to settle at 12,926. But certain stocks came in news after the market was closed. These stocks can impact the indices when it reopens on Tuesday, November 24, 2020. List of such five stocks:

IRCTC: The Company will be participating in non-deal roadshows and shall be meeting prospective investors from November 24, 2020, to November 27, 2020.

Coal India Limited (CIL): CIL Board approved to enhance the non-coking coal price by Rs 10 per tonne for Regulated and non-Regulated sectors across CIL towards contribution to the corpus of CMPS 1998. This would come into force from December 1, 2020. Besides, four trade unions of CIL has served one-day strike notice in CIL and its Subsidiaries on November 26, 2020.

TRENDING NOW

Ingersoll-Rand India Ltd.: Ingersoll-Rand INC has proposed to sell up to 14.25 lakh Equity Shares (representing up to 4.52% of the total issued and paid-up equity share capital) on November 24-25, 2020. The OFS will open for retail investors on November 24, 2020, and for retail investors on November 25, 2020. The floor price for the Sale shall be Rs. 578.60 per Equity Share. 12% discount on the Cut-Off Price is being offered to Retail Investors. The Sale is being undertaken by the Seller primarily to achieve the minimum public shareholding in the Company.

AstraZeneca Pharma India: Pune-based Serum Institute of India’s CEO has said he has the target to seek approval for usage of COVID-19 vaccine. The company would be able to supply around 40 crore doses of the vaccine by July. The maximum retail price for the private market of the vaccine will be up to Rs 1000. He has said, talks related to the purchase of the vaccine is on with the Government of India, however, there is no such agreement with the government yet. Poonawala said the SII is not entering into any agreement with other countries at this moment as India is its priority.

See Zee Business Live TV Streaming Below:

Real estate companies in focus: Naredco’s Maharashtra chapter has said its members will bear the stamp duty on housing sales till December 31, 2020, on behalf of home buyers to boost sales. Around 1000 builders are members of Naredco at present. The zero-stamp duty pushed Mumbai's residential realty sales by 300 per cent from August 2020 to October 2020.

TAGS: